Literature DB >> 20042575

LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells.

Plinio Hurtado1, Chen Au Peh.   

Abstract

LL-37 is a cationic antimicrobial peptide derived from neutrophils and keratinocytes. It plays an important role in protection against bacterial infection in the skin and mucosal surfaces. However, its role within the blood compartment remains unclear given that serum inhibits its bactericidal property. In this study, we show that LL-37 promotes very rapid and highly efficient sensing of CpG motifs in bacterial DNA by human B lymphocytes and plasmacytoid dendritic cells (pDCs) in serum-containing media and in whole blood. LL-37 allowed detection of CpG oligodeoxynucleotide (ODN) within minutes of exposure. Without LL-37, 20-30 times more CpG was required to produce the same effect. The promotion of CpG detection by LL-37 was independent of the backbone of the ODN, as the effect was observed not only in ODNs with modified phosphorothioate backbone, but also in ODNs with natural phosphodiester backbone, as found in genomic DNA. Unmethylated CpG motifs within the phosphodiester ODN and LL-37-mediated delivery are required for pDCs to respond. In keeping with the above, cells responded to CpG-rich bacterial DNA and LL-37, but not to human DNA and LL-37. The ability of LL-37 to enhance delivery of CpG to stimulate immune cells is independent of its amphipathic structure and its bactericidal property. LL-37 aids the delivery of CpG to B cells and pDCs, but not T cells. These findings are pertinent to rapid recognition of microbial DNA and are highly relevant to contemporary studies of CpG/TLR9 agonists in vaccines and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042575     DOI: 10.4049/jimmunol.0902305

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Antimicrobial peptides inhibit polyinosinic-polycytidylic acid-induced immune responses.

Authors:  Maroof Hasan; Catarina Ruksznis; Yan Wang; Cynthia Anne Leifer
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

Review 2.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.

Authors:  Ashley L Hilchie; Kelli Wuerth; Robert E W Hancock
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

Review 3.  Microbe-inducible trafficking pathways that control Toll-like receptor signaling.

Authors:  Yunhao Tan; Jonathan C Kagan
Journal:  Traffic       Date:  2016-11-23       Impact factor: 6.215

Review 4.  Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.

Authors:  William K K Wu; Guangshun Wang; Seth B Coffelt; Aline M Betancourt; Chung W Lee; Daiming Fan; Kaichun Wu; Jun Yu; Joseph J Y Sung; Chi H Cho
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

5.  Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.

Authors:  Cunbao Liu; Xiaojie Chu; Pengyan Sun; Xuejun Feng; Weiwei Huang; Hongxian Liu; Yanbing Ma
Journal:  Hum Vaccin Immunother       Date:  2018-01-23       Impact factor: 3.452

Review 6.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 7.  Modulation of toll-like receptor signaling by antimicrobial peptides.

Authors:  Ernest Y Lee; Michelle W Lee; Gerard C L Wong
Journal:  Semin Cell Dev Biol       Date:  2018-02-12       Impact factor: 7.727

Review 8.  The immunology of host defence peptides: beyond antimicrobial activity.

Authors:  Robert E W Hancock; Evan F Haney; Erin E Gill
Journal:  Nat Rev Immunol       Date:  2016-04-18       Impact factor: 53.106

9.  The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release.

Authors:  Susu M Zughaier; Pavel Svoboda; Jan Pohl; David S Stephens; William M Shafer
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 10.  What Can Pleiotropic Proteins in Innate Immunity Teach Us about Bioconjugation and Molecular Design?

Authors:  Michelle W Lee; Ernest Y Lee; Gerard C L Wong
Journal:  Bioconjug Chem       Date:  2018-06-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.